$CVKD Balance Sheet | Understand Stock

$CVKD

$0.94 +$0.03 (3.55%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Aug 6, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022
Current assets:
Prepaid expenses
Cash and cash equivalents
Receivable from issuance of warrants
Interest receivable
Prepaid expenses and other current assets
Deferred offering costs
Total current assets
Property, plant and equipment, net
Right of use assets
Other assets
Total assets
Current liabilities:
Accounts payable
Accrued liabilities
Operating lease liability
Promissory note payable, net of debt discount
Total current liabilities
Convertible note payable, net of debt discount - related parties

Convertible note payable, net of debt discount
Related Party
Total convertible note payable, net of debt discount
Derivative liabilities
Accrued interest
Operating lease liability, noncurrent
Total liabilities
Stockholders’ equity:
Common stock, $0.001 par value; 75,000,000 shares authorized, 3,098,592 shares issued and outstanding as of June 30, 2026; 2,338,127 shares issued and outstanding as of December 31, 2025
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments